Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.64M Sell
17,898
-13,043
-42% -$4.11M 1.21% 31
2026
Q1
$10.2M Buy
30,941
+229
+0.7% +$82.2K 2.24% 21
2025
Q4
$10.8M Sell
30,712
-1,145
-4% -$417K 2.58% 21
2025
Q3
$11.8M Buy
31,857
+444
+1% +$172K 2.75% 21
2025
Q2
$12.4M Buy
31,413
+355
+1% +$133K 3.14% 6
2025
Q1
$11.6M Sell
31,058
-1,252
-4% -$476K 3.19% 11
2024
Q4
$11.6M Buy
32,310
+111
+0.3% +$41.1K 3.12% 16
2024
Q3
$11.6M Buy
32,199
+584
+2% +$202K 2.75% 19
2024
Q2
$10.8M Buy
+31,615
New +$10.7M 2.7% 4

Other funds holding SYK

Paradiem's SYK Position: Q2 2026 in Review

Paradiem reduced its Stryker (SYK) stake by 42% in Q2 2026, selling an estimated $4.11M and leaving 17,898 shares worth $5.64M. The position accounts for 1.21% of the portfolio, ranked #31.

Paradiem first reported a position in SYK in Q2 2024 and has held it in 9 quarters since. The position peaked at $12.4M in Q2 2025. 1,044 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • Paradiem held 17,898 shares of Stryker worth $5.64M as of Q2 2026.
  • Paradiem sold 13,043 Stryker shares in Q2 2026, an estimated $4.11M.
  • Stryker made up 1.21% of Paradiem's portfolio in Q2 2026, its #31 holding.
  • Paradiem first reported a position in Stryker in Q2 2024 and has held it in 9 quarters since.
  • Paradiem's Stryker position peaked at $12.4M in Q2 2025.
  • 1,044 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on Paradiem's 13F filing for Q2 2026, filed 14 Jul 2026.